Caring Brands SEC Filings

Caring Brands Inc. entered into an expanded multi-territory licensing agreement with SanPellegrino Cosmetics Private Limited for its Photocil and Hair Enzyme Booster products. The revised agreement, effective May 21, 2026, introduces a five-year initial term with automatic annual renewal.

The deal broadens SCPL’s licensed territory beyond India to include multiple LATAM countries, Russia, Australia and New Zealand, leveraging existing sublicense partnerships with Eris Lifesciences and Glenmark Pharmaceuticals. Caring Brands highlights that this expansion supports its strategy to grow revenue from patented, clinically validated skin and hair-growth products across high-growth international markets.

Caring Brands, Inc. filed a current report to correct an administrative error in its proxy materials. The company’s Definitive Proxy Statement for its annual meeting had incorrectly listed May 12, 2026 as the record date. The correct record date for determining stockholders entitled to receive notice of, and vote at, the annual meeting is May 14, 2026.

All other information in the original proxy statement remains unchanged, and only stockholders of record as of May 14, 2026 will be eligible to participate in the meeting. The company plans to file a revised definitive proxy statement reflecting this corrected date.

Caring Brands, Inc. filed a current report to correct an administrative error in its proxy materials. The company’s Definitive Proxy Statement for its annual meeting had incorrectly listed May 12, 2026 as the record date. The correct record date for determining stockholders entitled to receive notice of, and vote at, the annual meeting is May 14, 2026.

All other information in the original proxy statement remains unchanged, and only stockholders of record as of May 14, 2026 will be eligible to participate in the meeting. The company plans to file a revised definitive proxy statement reflecting this corrected date.

Caring Brands, Inc. has called a July 9, 2026 special meeting to approve several capital-structure changes tied to a March 19, 2026 financing. The company agreed to sell up to $3,600,000 of Series A Convertible Preferred Stock and five-year Warrants to institutional and accredited investors.

Shareholders are asked to approve an Additional Investment Right allowing investors to buy more Series A and Warrants, authorize issuing common shares on conversion and exercise above 19.99% of prior outstanding stock, increase authorized common from 100,000,000 to 500,000,000 shares, and permit adjournments to solicit more proxies.

Caring Brands, Inc. has called a July 9, 2026 special meeting to approve several capital-structure changes tied to a March 19, 2026 financing. The company agreed to sell up to $3,600,000 of Series A Convertible Preferred Stock and five-year Warrants to institutional and accredited investors.

Shareholders are asked to approve an Additional Investment Right allowing investors to buy more Series A and Warrants, authorize issuing common shares on conversion and exercise above 19.99% of prior outstanding stock, increase authorized common from 100,000,000 to 500,000,000 shares, and permit adjournments to solicit more proxies.

Caring Brands, Inc. received a Nasdaq Staff Delisting Determination after falling out of compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2.5 million in stockholders’ equity. The company’s latest Form 10-K reported stockholders’ equity of $2,091,324, triggering the notice.

Caring Brands has 45 days, until May 22, 2026, to submit a plan to regain compliance and could receive up to 180 days, until October 4, 2026, to demonstrate compliance if Nasdaq accepts the plan. The notice does not immediately affect trading, and the stock continues to trade on Nasdaq under the symbol CABR, but failure to regain compliance could lead to delisting.

Caring Brands, Inc. received a Nasdaq Staff Delisting Determination after falling out of compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2.5 million in stockholders’ equity. The company’s latest Form 10-K reported stockholders’ equity of $2,091,324, triggering the notice.

Caring Brands has 45 days, until May 22, 2026, to submit a plan to regain compliance and could receive up to 180 days, until October 4, 2026, to demonstrate compliance if Nasdaq accepts the plan. The notice does not immediately affect trading, and the stock continues to trade on Nasdaq under the symbol CABR, but failure to regain compliance could lead to delisting.

Caring Brands, Inc. files its annual report describing a wellness consumer products business that remains in early stages with minimal revenue and significant losses. The company reports a net loss of $6,278,191 for the year ended December 31, 2025, following a net loss of $1,517,431 for 2024, and its auditors raise substantial doubt about its ability to continue as a going concern.

The business centers on over-the-counter and cosmetic products such as Photocil for psoriasis and vitiligo, the Hair Enzyme Booster (JW-700) to enhance minoxidil, and CB-101 for eczema, supported by multiple clinical trials and patents. Licensing agreements with partners including Taisho in Japan and Cosmofix/San Pellegrino in India and other territories underpin its commercialization strategy, while most products use GRASE ingredients under OTC or cosmetic frameworks.

The company is authorized to issue 100,000,000 common shares at $0.001 par value and reports 13,336,925 shares outstanding as of June 30, 2025 and 12,341,506 shares outstanding as of March 30, 2026. Caring Brands qualifies as an emerging growth company and smaller reporting company, using scaled disclosure and extended transition for new accounting standards, and highlights extensive regulatory, competitive, funding, and execution risks.

Caring Brands, Inc. files its annual report describing a wellness consumer products business that remains in early stages with minimal revenue and significant losses. The company reports a net loss of $6,278,191 for the year ended December 31, 2025, following a net loss of $1,517,431 for 2024, and its auditors raise substantial doubt about its ability to continue as a going concern.

The business centers on over-the-counter and cosmetic products such as Photocil for psoriasis and vitiligo, the Hair Enzyme Booster (JW-700) to enhance minoxidil, and CB-101 for eczema, supported by multiple clinical trials and patents. Licensing agreements with partners including Taisho in Japan and Cosmofix/San Pellegrino in India and other territories underpin its commercialization strategy, while most products use GRASE ingredients under OTC or cosmetic frameworks.

The company is authorized to issue 100,000,000 common shares at $0.001 par value and reports 13,336,925 shares outstanding as of June 30, 2025 and 12,341,506 shares outstanding as of March 30, 2026. Caring Brands qualifies as an emerging growth company and smaller reporting company, using scaled disclosure and extended transition for new accounting standards, and highlights extensive regulatory, competitive, funding, and execution risks.

Caring Brands, Inc. entered into a $3.6 million private investment in public equity, issuing 3,789.74 shares of Series A Convertible Preferred Stock at $950 per share with a stated value of $1,000 and an 8% dividend. The preferred stock is convertible into common shares at $0.40 and is paired with 9,473,685 common warrants, also exercisable at $0.40 for five years, all subject to beneficial ownership limits and a 19.99% cap without shareholder approval.

The company plans to use $3.075 million of the proceeds to repurchase 6,250,000 common shares from insiders, reducing common shares outstanding from 14,761,925 to 8,511,925, with the balance for general corporate and working capital needs. The investor also obtained an option to invest up to an additional $4.0 million on similar terms and received a 12‑month right of first refusal on future financings, while the company agreed to register the resale of the underlying shares.

Caring Brands, Inc. entered into a $3.6 million private investment in public equity, issuing 3,789.74 shares of Series A Convertible Preferred Stock at $950 per share with a stated value of $1,000 and an 8% dividend. The preferred stock is convertible into common shares at $0.40 and is paired with 9,473,685 common warrants, also exercisable at $0.40 for five years, all subject to beneficial ownership limits and a 19.99% cap without shareholder approval.

The company plans to use $3.075 million of the proceeds to repurchase 6,250,000 common shares from insiders, reducing common shares outstanding from 14,761,925 to 8,511,925, with the balance for general corporate and working capital needs. The investor also obtained an option to invest up to an additional $4.0 million on similar terms and received a 12‑month right of first refusal on future financings, while the company agreed to register the resale of the underlying shares.

Caring Brands, Inc. reported that it has been issued two new United States patents. These patents cover proprietary methods and compositions that enhance enzymatic activity in hair follicles. Management explains that this intellectual property further strengthens protection around its Hair Enzyme Booster product and related technologies, potentially reinforcing its competitive position in hair-focused treatments.

Caring Brands, Inc. reported that it has been issued two new United States patents. These patents cover proprietary methods and compositions that enhance enzymatic activity in hair follicles. Management explains that this intellectual property further strengthens protection around its Hair Enzyme Booster product and related technologies, potentially reinforcing its competitive position in hair-focused treatments.

Caring Brands, Inc. completed an initial public offering of 1,000,000 shares of common stock at $4.00 per share, raising approximately $4.00 million in gross proceeds and about $3.23 million in net proceeds. The deal was a firm commitment underwriting with D. Boral Capital LLC and includes a 45-day over-allotment option for up to 150,000 additional shares at the offering price, less the underwriting discount.

As part of the transaction, the underwriter received a warrant to purchase up to 30,000 shares of common stock at an exercise price of $4.00 per share, exercisable for five years starting 180 days after the closing, with up to about 4,500 additional warrant shares if the over-allotment is exercised. Company officers, directors, and 10% holders agreed to a 180-day lock-up on sales of common stock and related securities. The common stock was approved for listing on Nasdaq under the symbol CABR and began trading on November 13, 2025.

Caring Brands, Inc. (CABR) disclosed that its Chief Financial Officer, Tyler Moore, filed an initial insider ownership report on Form 3 in connection with an event dated 10/30/2025. Moore is identified as an officer, specifically the Chief Financial Officer, and the filing is made by one reporting person. In the ownership tables for both non-derivative and derivative securities, the explanation states that no securities are beneficially owned, meaning the CFO reported no direct or indirect holdings of Caring Brands stock or related derivative securities as of the event date.

Caring Brands, Inc.10/30/2025director of the company and beneficially owns 50,000 shares of Caring Brands common stock in direct form. The filing does not list any derivative securities such as options or warrants for this reporting person.